Intranasal Esketamine-dexmedetomidine Combination and Postpartum Depression

Clinical trial NCT07639099 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07639099
Sponsor: Peking University First Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Parturients Depressive Symptoms Esketamine Dexmedetomidine Intranasal Administration Postpartum Depression

Start date: 2026-06-01
Primary completion: 2029-10-01
Enrollment: 164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.